Catriona Parker

Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial

Catriona Parker, Rachel Waters, Carly Leighton et al. · The Lancet · 2010 · 335 citations · Full text

Medicine, Oncology, Pediatrics +14

Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia

Julie Irving, Amir Enshaei, Catriona Parker et al. · Blood · 2016 · 135 citations · Full text

Medicine, Genetics, Oncology +9

EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications

Claire Schwab, Sarra Ryan, Lucy Chilton et al. · Blood · 2016 · 132 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial

Alexander C. Ford, Alexandra Wright‐Hughes, Sarah Alderson et al. · The Lancet · 2023 · 124 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

Reversing Hypoxic Cell Chemoresistance in Vitro Using Genetic and Small Molecule Approaches Targeting Hypoxia Inducible Factor-1

Louisa M. Brown, Rachel Cowen, Camille Debray et al. · Molecular Pharmacology · 2005 · 122 citations

Medicine, Oncology, Pharmacology +14